Doximity, Inc. (DOCS) is a publicly traded Healthcare sector company. As of May 20, 2026, DOCS trades at $19.65 with a market cap of $3.62B and a P/E ratio of 15.59. DOCS moved +3.30% today. Year to date, DOCS is -56.53%; over the trailing twelve months it is -62.53%. Its 52-week range spans $17.15 to $85.21. Analyst consensus is buy with an average price target of $26.78. Rallies surfaces DOCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DOCS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DOCS recently traded at $19.65. Market cap is $3.62B. P/E ratio is 15.59. Revenue is $637.78M.
| Metric | Value |
|---|---|
| Price | $19.65 |
| Market Cap | $3.62B |
| P/E Ratio | 15.59 |
| EPS | $1.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.21 |
| 52-Week Low | $17.15 |
| Volume | 3.63M |
| Avg Volume | 0 |
| Revenue (TTM) | $637.78M |
| Net Income | $239.40M |
| Gross Margin | 89.75% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $570.40M | $223.19M | $1.19 |
| 2024 | $475.42M | $147.58M | $0.78 |
| 2023 | $419.05M | $112.82M | $0.58 |
| 2022 | $343.55M | $154.78M | $0.82 |
21 analysts cover DOCS: 0 strong buy, 9 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.78.